Dreicer, Jessica J.
Mailankody, Sham
Fakhrejahani, Farhad
Prasad, Vinay
Article History
Received: 17 August 2017
Accepted: 23 August 2017
First Online: 14 December 2017
Competing interests
: Dr. Dreicer and Fahkrejahani—none; Dr Mailankody reported serving as a principal investigator for clinical trials with research funding from Juno Therapeutics and Takeda Oncology. Dr Mailankody reported receiving personal fees for speaking at the Wedbush Pacgrow Healthcare Conference 2016. Dr Prasad’s research is funded by the Laura and John Arnold Foundation. Dr Mailankody is supported in part by support grant/core grant P30 CA008748 from the National Cancer Institute Memorial Sloan Kettering Cancer Center.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.